Alpha 2.0
Login Register
» Authors » Amro Mohamed Sedky El-Ghammaz

Amro Mohamed Sedky El-Ghammaz

Explore the profile of Amro Mohamed Sedky El-Ghammaz including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 24
Followers 0
Related Specialties
Hematology
General Medicine
Oncology
Top 10 Co-Authors
Mohamed Osman Azzazi
Mohamed Mahmoud Moussa
Hany Mohamed Hegab
Essam Abdelwahed
Mohamad Ayed Mohamad
Hebatullah Magdy Fares
Maha El-Zimaity
Mohammed Magdy Maher
Mohamed Gamal Kotob
Hoda Ahmed Gadallah
Published In
Indian J Hematol Blood Transfus
Clin Exp Med
Support Care Cancer
Affiliations
Soon will be listed here.
Recent Articles
1.
Impact of serum soluble CD155 level at diagnosis on interim response to CHOP with or without rituximab in diffuse large B cell lymphoma
Azzazi M, Hegab H, El-Ghammaz A, Saber H, Afifi Y
Clin Exp Med . 2021 Jul; 22(2):173-181. PMID: 34216302
CD155 is frequently overexpressed in human malignant tumors, and it is associated with poor prognosis. The expression of its soluble form (sCD155) as well as its prognostic value were not...
2.
Prognostic Impact of Serum Growth Differentiation Factor 15 Level in Acute Myeloid Leukemia Patients
Hegab H, El-Ghammaz A, El-Razzaz M, Helal R
Indian J Hematol Blood Transfus . 2021 Mar; 37(1):37-44. PMID: 33707833
Growth differentiation factor 15 (GDF15) plays an important role in cancer pathophysiology and prognosis. However, limited studies analyzed its level and prognostic value in acute myeloid leukemia (AML) patients. This...
3.
Effectiveness and Cost-Effectiveness of Prophylactic Voriconazole and Fluconazole Regarding Prevention of Post-hematopoietic Stem Cell Transplantation Invasive Fungal Infection and Its Related Death: A Single Center Experience
El-Ghammaz A, El-Zimaity M, Elafifi A, Abdelwahed E, Moussa M, Aboelmagd Y, et al.
Indian J Hematol Blood Transfus . 2020 Oct; 36(4):680-689. PMID: 33100710
Purpose: Analyzing effectiveness and cost-effectiveness of voriconazole versus fluconazole prophylaxis in hematopoietic stem cell transplantation (HSCT). Methods: The research included 70 patients; 34 undergoing allogeneic HSCT and 36 undergoing autologous...
4.
Impact of Additional Chromosomal Aberrations Present at Diagnosis on Outcome of Adolescent and Young Adult Chronic Myeloid Leukemia Patients: A Single Center Experience
El-Ghammaz A, Hamza M, Said R, Moussa M, Eissa A, Azzazi M
Indian J Hematol Blood Transfus . 2019 Nov; 35(4):683-691. PMID: 31741620
Studying the influence of additional chromosomal aberrations (ACAs) present at diagnosis on the outcome of adolescent and young adult (AYA) chronic myeloid leukemia (CML) patients as it has not been...
5.
Impact of serum soluble programed death ligand 1 on end of treatment metabolic response of diffuse large B cell lymphoma patients
El-Ghammaz A, Gadallah H, Kamal G, Maher M, Mohamad M
Clin Exp Med . 2018 Jun; 18(4):505-512. PMID: 29876769
Programmed death ligand-1 (PD-L1) plays an important role in the immune evasion of cancer cells and, in turn, can influence the outcome of many malignancies. The serum soluble PD-L1 (sPD-L1)...
6.
Bacteremia During Early Post-allogeneic Hematopoietic Stem Cell Transplantation Period: A Single Center Experience
El-Ghammaz A
Indian J Hematol Blood Transfus . 2017 Jun; 33(2):200-206. PMID: 28596651
Bacteremia is a significant complication of allogeneic hematopoietic stem cell transplantation (HSCT). We aimed to study bacteremia occurring during early post-transplant period at Bone Marrow Transplantation Unit of Ain Shams...
7.
Nutritional status of allogeneic hematopoietic stem cell transplantation recipients: influencing risk factors and impact on survival
El-Ghammaz A, Ben Matoug R, Elzimaity M, Mostafa N
Support Care Cancer . 2017 Apr; 25(10):3085-3093. PMID: 28439725
Purpose: Patients subjected to allogeneic hematopoietic stem cell transplantation (HSCT) are at increased nutritional risk which in turn may alter their outcome. For providing good nutritional care for patients, it...